Abstract
To determine the efficacy of preoperative concurrent chemoradiation therapy (CCRT) to improve the prognosis of locally advanced adenocarcinoma of the uterine cervix. Twenty-five patients with clinical stage IB2-IVB adenocarcinoma of the cervix were received preoperative CCRT. The CCRT protocol included: external radiotherapy to the pelvis: 39.6 Gy; intra-arterial or intravenous infusion of 70 mg/m2 cisplatin, days 1 and 22; 24-h continuous intravenous infusion of 700 mg/m2 5-FU, days 1-4 and 22-25. Two weeks after the end of CCRT, patients underwent restaging followed by appropriate surgery with pelvic lymphadenectomy. The overall clinical response rate was 96% (24/25), with a complete response (CR) in 12/25 patients and partial response (PR) in 12/25. On pathological examination, 5 of 19 patients (26%) undergoing surgery showed a pathological CR, 13 patients showed a PR, and 1 patient no change (NC) in their disease. Grade 3 or 4 hematological toxicity was observed in 15 patients. Grade 3 gastrointestinal toxicity was observed in 8 patients. The median follow-up period was 34 months (range, 6-69). The 5-year overall survival (OS) rate was 84%, and the progression-free survival (PFS) rate was 76%. Preoperative CCRT improves the...Continue Reading
References
Sep 1, 1983·Cancer·I Milsom, L G Friberg
Feb 1, 1997·Current Opinion in Obstetrics & Gynecology·M A Quinn
Apr 1, 1996·International Journal of Epidemiology·T ZhengP Boyle
Mar 30, 1999·Gynecologic Oncology·H IshikawaK Kuzuya
Apr 15, 1999·The New England Journal of Medicine·M MorrisD G Mutch
Jul 1, 1999·Gynecologic Oncology·M JuradoA Brugarolas
Apr 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W A PetersD S Alberts
Aug 6, 2000·Gynecologic Oncology·H O SmithC R Key
Sep 14, 2000·Gynecologic Oncology·S MancusoN Cellini
May 1, 1995·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R. AttanoosS.M. Ismail
Dec 26, 2001·Gynecologic Oncology·Jayanthi S LeaJohn O Schorge
Dec 26, 2001·Cancer·D GrisaruB Rosen
Dec 13, 2003·Gynecologic and Obstetric Investigation·Kiyosumi ShibataShigehiko Mizutani
Jan 31, 2004·Gynecologic Oncology·A BaalbergenTh J M Helmerhorst
Nov 13, 2004·Oncology·Mariagrazia DistefanoGiovanni Scambia
Oct 11, 2005·Gynecologic Oncology·Gilles HouvenaeghelMichel Resbeut
Jan 4, 2006·American Journal of Obstetrics and Gynecology·Riadh CharguiKhaled Rahal
Citations
Apr 24, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L CetinaA Dueñas-González
Jan 15, 2015·International Journal of Radiation Oncology, Biology, Physics·Gabriella FerrandinaVincenzo Valentini
Sep 15, 2012·Human Pathology·Hiroaki KajiyamaFumitaka Kikkawa
Jan 29, 2010·Gynecologic Oncology·Jen-Tsun LinCheng-Shong Chang
May 23, 2012·The Journal of Obstetrics and Gynaecology Research·Tae-Eung KimSei-Chul Yoon
Aug 8, 2015·Materials Science & Engineering. C, Materials for Biological Applications·Cheng WangJianping Zhou
Feb 14, 2012·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Won-Moo LeeSang-Young Ryu
Mar 22, 2018·BMC Cancer·Dan ShiXiaodong Liu
Mar 26, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Domenica LorussoFrancesco Raspagliesi
Nov 22, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Hiroshi TsubamotoShozo Hirota
Dec 21, 2013·British Journal of Cancer·S Y RyuJ-H Nam
May 13, 2021·Acta Radiologica·Wei WangYajia Gu
Jan 27, 2010·Current Opinion in Supportive and Palliative Care